Monogram Orthopaedics Inc. (MGRM) Peer Comparison
$6.00
$0.00 (0.00%)As on 08-Oct-2025 09:30EDT
Market cap
$244 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
28
Div. Yield
0 %
| Monogram Orthopaedics Inc. (MGRM) | Biosig Technologies Inc (BSGM) | |
|---|---|---|
Market cap ($ Mln) |
244 | 215 |
Revenue ($ Mln) |
0 | 0 |
Net Profit ($ Mln) |
-17.91 | -26.20 |
Net Margin (%) |
-4,210.19 | -201,515.38 |
RoE (%) |
-154.96 | -- |
Price to Earnings |
-- | -- |
Price-To-Book |
27.98 | 36.58 |
Income Statement ($ Mln)
| Monogram Orthopaedics Inc. (MGRM) | Biosig Technologies Inc (BSGM) | |
|---|---|---|
|
Operating Revenue
|
0.43 | 0.01 |
|
Cost of Revenue
|
0.58 | 0.00 |
|
Gross Profit
|
-0.43 | -- |
|
Operating Expenses
|
14.32 | 27.50 |
|
Operating Profit (EBIT)
|
-14.47 | -27.48 |
|
Other Income
|
0.00 | 0.00 |
|
Profit before Tax
|
-17.91 | -26.18 |
|
Provision for Tax
|
0.00 | 0.00 |
|
Profit after Tax (Net Income)
|
-17.91 | -26.20 |
|
Minority Interest
|
0.00 | -0.02 |
|
Consolidated Profit
|
0.00 | 0.00 |
Liabilities ($ Mln)
| Monogram Orthopaedics Inc. (MGRM) | Biosig Technologies Inc (BSGM) | |
|---|---|---|
|
Shareholder's Funds
|
8.62 | -3.51 |
|
Minority Interest
|
0.00 | -0.02 |
|
Non-Current Liabilities
|
0.15 | 0.00 |
|
Current Liabilities
|
6.23 | 113.20 |
|
Total Liabilities
|
17.77 | 0.84 |
Assets ($ Mln)
| Monogram Orthopaedics Inc. (MGRM) | Biosig Technologies Inc (BSGM) | |
|---|---|---|
|
Non-Current Assets
|
1.54 | 106.72 |
|
Current Assets
|
13.46 | 3.00 |
|
Total Assets
|
17.77 | -- |
|
Total Debt*
|
0.30 | 0.00 |
|
Net Current Assets
|
7.23 | -110.20 |
Cashflow ($ Mln)
| Monogram Orthopaedics Inc. (MGRM) | Biosig Technologies Inc (BSGM) | |
|---|---|---|
|
Cash From Operating Activities
|
-13.97 | -4.76 |
|
Cash Flow from Investing Activities
|
-0.08 | -- |
|
Cash from Financing Activities
|
16.12 | 4.71 |
|
Net Cash Inflow / Outflow
|
-- | -- |
Ratios
Profitability Ratios
| Monogram Orthopaedics Inc. (MGRM) | Biosig Technologies Inc (BSGM) | |
|---|---|---|
|
ROCE (%)
|
-113.56 | 529.74 |
|
ROE (%)
|
-154.96 | 474.72 |
|
ROA (%)
|
-106.88 | -22.88 |
|
EBIT Margin (%)
|
-3,436.13 | -211,400.00 |
|
Net Margin (%)
|
-4,210.19 | -201,515.38 |
|
Cash Profit Margin (%)
|
-0.01 | -0.32 |
Growth Ratios
| Monogram Orthopaedics Inc. (MGRM) | Biosig Technologies Inc (BSGM) | |
|---|---|---|
|
Revenue Growth (%)
|
16.57 | -65.79 |
|
EBIT Growth (%)
|
1.73 | -26.79 |
|
Net Profit Growth (%)
|
-53.19 | -27.28 |
|
EPS Growth (%)
|
-41.89 | -- |
|
Book Value Growth (%)
|
8.75 | -- |
Valuation Ratios
| Monogram Orthopaedics Inc. (MGRM) | Biosig Technologies Inc (BSGM) | |
|---|---|---|
|
Price / Earnings
|
-4.73 | -- |
|
Price / Book Value
|
5.32 | -- |
|
Dividend Yield (%)
|
-- | -- |
|
EV/EBITDA
|
-3.89 | -- |
|
Market Cap ($ Cr)
|
-- | -- |
Solvency Ratios
| Monogram Orthopaedics Inc. (MGRM) | Biosig Technologies Inc (BSGM) | |
|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 |
|
Short term debt to equity ratio
|
0.02 | 0.00 |
|
Current Ratio
|
2.16 | 0.03 |
|
Quick Ratio
|
2.11 | 0.03 |
|
Interest Coverage
|
-- | -- |
Operating Efficiency Ratios
| Monogram Orthopaedics Inc. (MGRM) | Biosig Technologies Inc (BSGM) | |
|---|---|---|
|
Debtors to sales (%)
|
22.80 | 0.00 |
|
Asset Turnover
|
0.03 | 0.00 |
|
Receivable days
|
-- | 607.23 |
|
Inventory Days
|
122.32 | -- |
|
Payable days
|
1,544.36 | -- |
|
Cash Conversion Cycle
|
-- | -- |